Stock Price

0,01 USD

-57.26% ROA

-82.07% ROE

0x PER

Market Cap.

0,00 USD

0% DER

0% Yield

-447.76% NPM

Sigma Labs Inc. Warrant Stock Analysis

Sigma Labs Inc. Warrant Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Sigma Labs Inc. Warrant Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (8%), which means it has a small amount of debt compared to the ownership it holds

3 Assets Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

4 ROE

Negative ROE (-82.07%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-57.26%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Sigma Labs Inc. Warrant Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Sigma Labs Inc. Warrant Technical Stock Analysis
# Analysis Recommendation

Sigma Labs Inc. Warrant Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Sigma Labs Inc. Warrant Revenue
Year Revenue Growth
2001 1.267
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 498.504 100%
2011 797.354 37.48%
2012 986.499 19.17%
2013 1.071.439 7.93%
2014 548.723 -95.26%
2015 1.234.810 55.56%
2016 966.422 -27.77%
2017 641.049 -50.76%
2018 388.574 -64.97%
2019 402.446 3.45%
2020 807.488 50.16%
2021 1.396.960 42.2%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Sigma Labs Inc. Warrant Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 219.132 100%
2015 330.554 33.71%
2016 92.992 -255.46%
2017 302.043 69.21%
2018 493.410 38.78%
2019 647.994 23.86%
2020 351.404 -84.4%
2021 1.126.964 68.82%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Sigma Labs Inc. Warrant General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 8.984 100%
2010 801.387 98.88%
2011 1.296.200 38.17%
2012 1.117.668 -15.97%
2013 1.230.242 9.15%
2014 2.006.866 38.7%
2015 2.387.096 15.93%
2016 3.158.494 24.42%
2017 3.783.691 16.52%
2018 4.866.660 22.25%
2019 5.212.561 6.64%
2020 5.172.425 -0.78%
2021 8.834.968 41.46%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Sigma Labs Inc. Warrant EBITDA
Year EBITDA Growth
2001 -5.983
2002 -5.366 -11.5%
2003 -5.955 9.89%
2004 -6.504 8.44%
2005 -6.192 -5.04%
2006 -6.317 1.98%
2007 -6.916 8.66%
2008 -6.457 -7.11%
2009 -8.984 28.13%
2010 -391.007 97.7%
2011 -888.844 56.01%
2012 -575.275 -54.51%
2013 -634.017 9.27%
2014 -3.093.431 79.5%
2015 -1.527.230 -102.55%
2016 -2.017.993 24.32%
2017 -4.218.721 52.17%
2018 -5.377.823 21.55%
2019 -6.119.595 12.12%
2020 -5.081.056 -20.44%
2021 -9.495.948 46.49%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Sigma Labs Inc. Warrant Gross Profit
Year Gross Profit Growth
2001 1.267
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 391.441 100%
2011 384.958 -1.68%
2012 431.671 10.82%
2013 582.812 25.93%
2014 389.787 -49.52%
2015 1.020.806 61.82%
2016 737.520 -38.41%
2017 368.677 -100.05%
2018 118.467 -211.21%
2019 -171.855 168.93%
2020 215.531 179.74%
2021 795.072 72.89%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Sigma Labs Inc. Warrant Net Profit
Year Net Profit Growth
2001 -5.983
2002 -5.366 -11.5%
2003 -5.955 9.89%
2004 -6.504 8.44%
2005 -6.192 -5.04%
2006 -6.317 1.98%
2007 -6.916 8.66%
2008 -7.642 9.5%
2009 -10.184 24.96%
2010 -421.946 97.59%
2011 -910.129 53.64%
2012 -685.566 -32.76%
2013 -734.117 6.61%
2014 -3.116.080 76.44%
2015 -1.696.282 -83.7%
2016 -2.196.834 22.79%
2017 -4.577.516 52.01%
2018 -5.574.163 17.88%
2019 -6.320.849 11.81%
2020 -5.200.139 -21.55%
2021 -9.613.000 45.91%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Sigma Labs Inc. Warrant Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Sigma Labs Inc. Warrant Free Cashflow
Year Free Cashflow Growth
2001 -3.783
2002 -37 -10124.32%
2003 -50 26%
2004 -5.030 99.01%
2005 -9.265 45.71%
2006 -1.856 -399.19%
2007 -3.239 42.7%
2008 -4.352 25.57%
2009 -250 -1640.8%
2010 -528.236 99.95%
2011 -597.533 11.6%
2012 -503.384 -18.7%
2013 -338.456 -48.73%
2014 -1.728.170 80.42%
2015 -1.412.260 -22.37%
2016 -2.050.140 31.11%
2017 -2.931.866 30.07%
2018 -3.991.496 26.55%
2019 -5.722.516 30.25%
2020 -5.108.727 -12.01%
2021 -1.617.347 -215.87%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Sigma Labs Inc. Warrant Operating Cashflow
Year Operating Cashflow Growth
2001 -3.783
2002 -37 -10124.32%
2003 -50 26%
2004 -5.030 99.01%
2005 -9.265 45.71%
2006 -1.856 -399.19%
2007 -3.239 42.7%
2008 -4.352 25.57%
2009 -250 -1640.8%
2010 -528.236 99.95%
2011 -575.469 8.21%
2012 -481.924 -19.41%
2013 -311.299 -54.81%
2014 -888.560 64.97%
2015 -1.259.685 29.46%
2016 -1.962.314 35.81%
2017 -2.791.406 29.7%
2018 -3.762.971 25.82%
2019 -5.514.805 31.77%
2020 -4.809.868 -14.66%
2021 -1.512.369 -218.04%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Sigma Labs Inc. Warrant Capital Expenditure
Year Capital Expenditure Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 22.064 100%
2012 21.460 -2.81%
2013 27.157 20.98%
2014 839.610 96.77%
2015 152.575 -450.29%
2016 87.826 -73.72%
2017 140.460 37.47%
2018 228.525 38.54%
2019 207.711 -10.02%
2020 298.859 30.5%
2021 104.978 -184.69%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Sigma Labs Inc. Warrant Equity
Year Equity Growth
2002 464
2003 -577 180.42%
2004 -81 -612.35%
2005 -6.273 98.71%
2006 -12.590 50.17%
2007 -15.986 21.24%
2008 -23.628 32.34%
2009 -27.012 12.53%
2010 430.358 106.28%
2011 1.101.494 60.93%
2012 557.770 -97.48%
2013 1.280.312 56.43%
2014 3.805.991 66.36%
2015 2.677.348 -42.16%
2016 977.038 -174.03%
2017 3.011.916 67.56%
2018 1.735.439 -73.55%
2019 652.249 -166.07%
2020 5.163.732 87.37%
2021 12.859.751 59.85%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Sigma Labs Inc. Warrant Assets
Year Assets Growth
2002 2.090
2003 2.040 -2.45%
2004 4.010 49.13%
2005 4.745 15.49%
2006 2.889 -64.24%
2007 2.422 -19.28%
2008 298 -712.75%
2009 48 -520.83%
2010 475.354 99.99%
2011 1.276.196 62.75%
2012 691.712 -84.5%
2013 1.421.473 51.34%
2014 4.160.341 65.83%
2015 2.787.264 -49.26%
2016 1.869.369 -49.1%
2017 3.394.810 44.93%
2018 2.431.258 -39.63%
2019 1.691.468 -43.74%
2020 5.700.510 70.33%
2021 13.840.990 58.81%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Sigma Labs Inc. Warrant Liabilities
Year Liabilities Growth
2002 1.626
2003 2.617 37.87%
2004 4.091 36.03%
2005 11.018 62.87%
2006 15.479 28.82%
2007 18.408 15.91%
2008 23.926 23.06%
2009 27.060 11.58%
2010 44.996 39.86%
2011 174.702 74.24%
2012 133.942 -30.43%
2013 141.161 5.11%
2014 354.350 60.16%
2015 109.916 -222.38%
2016 892.331 87.68%
2017 382.894 -133.05%
2018 695.819 44.97%
2019 1.039.219 33.04%
2020 536.778 -93.6%
2021 981.239 45.3%

Sigma Labs Inc. Warrant Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
0x
Price To Sales Ratio
0x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
0
EV to Sales
-6.93
EV Over EBITDA
1.57
EV to Operating CashFlow
1.82
EV to FreeCashFlow
1.72
Earnings Yield
0
FreeCashFlow Yield
0
Market Cap
0,00 Bil.
Enterprise Value
-0,01 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0
Income Quality
0.85
ROE
-0.82
Return On Assets
-0.53
Return On Capital Employed
-0.57
Net Income per EBT
1
EBT Per Ebit
1
Ebit per Revenue
-4.46
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
4.98
Research & Developement to Revenue
0.54
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.66
Operating Profit Margin
-4.46
Pretax Profit Margin
-4.47
Net Profit Margin
-4.48

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0.06
Capex to Revenue
-0.22
Capex to Depreciation
-3.82
Return on Invested Capital
-0.57
Return on Tangible Assets
-0.57
Days Sales Outstanding
91.08
Days Payables Outstanding
134.56
Days of Inventory on Hand
462.85
Receivables Turnover
4.01
Payables Turnover
2.71
Inventory Turnover
0.79
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
1.57
Current Ratio
12.93
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.07
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
684865.5
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Sigma Labs Inc. Warrant Dividends
Year Dividends Growth

Sigma Labs Inc. Warrant Profile

About Sigma Labs Inc. Warrant

CEO
None
Employee
0
Address

,

Sigma Labs Inc. Warrant Executives & BODs

Sigma Labs Inc. Warrant Executives & BODs
# Name Age

Sigma Labs Inc. Warrant Competitors